Atrion Corporation designs, develops, manufactures, markets, sells, and distributes medical products and components. The Company's products are used in ophthalmic, diagnostic, and cardiovascular procedures.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Atrion news
25.05.2022
The Atrion Board of Directors announced a quarterly dividend of $1.95 per share. The last day to buy securities to receive the dividend is June 13, 2022. The annual dividend yield may reach 1.1%.
Source: atrion.irpass.com
10.05.2022
Atrion's GAAP net income for 3 months of 2022 was $8.499 million, up 10% from $7.726 million in the previous year. Revenue increased 20.3% to $47.138 million from $39.169 million a year earlier.
Source: atrion.irpass.com
28.02.2022
Atrion's GAAP net income for 2021 was $33.055 million, up 2.9% from $32.115 million in the previous year. Revenue increased 11.8% to $165.009 million from $147.591 million a year earlier.
Source: atrion.irpass.com
28.02.2022
The Atrion Board of Directors announced a quarterly dividend of $1.95 per share. The last day to buy securities to receive the dividend is March 10, 2022. The annual dividend yield may reach 1.08%.
Source: atrion.irpass.com
General information
| Company name | Atrion |
|---|---|
| Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies |
| Business address | ONE ALLENTOWN PARKWAY ALLEN TX 75002 9723909800 |
| Mailing address | ONE ALLENTOWN PARKWAY ALLEN TX 75002 |
| Website | atrioncorp.com |
| Information disclosure | www.sec.gov |
English (US) 